Search Within

Population Sciences Research Program

  1. "Nursing"
  2. "American Society of Hematology"
  3. "Mikhail Roshal"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Advanced Practice Providers (5)
  2. Biostatistics Service (5)
  3. Center for Hematologic Malignancies (5)
  4. Department of Medicine (5)
  5. Epidemiology and Biostatistics (5)
  6. Hematologic Malignancies, Division of (5)

More Groups

People
  1. Andriy Derkach (5)
  2. Mikhail Roshal (5)
  3. Aaron Goldberg (3)
  4. Alexander Chan (3)
  5. Amber King (3)
  6. Anthony Daniyan (3)

More People

Years
  1. 2021 (1)
  2. 2020 (4)
Publications
  1. Blood (4)
  2. Blood Advances (1)
Publishers
  1. American Society of Hematology (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma: final results from a clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Diamond, B.; Salcedo, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    Blood (2020)

    Fulltext@MSK | Save